• Biotech

Research Coverage

  • Allogene Therapeutics, Inc. (ALLO)
  • Bicycle Therapeutics Plc (BCYC)
  • Geron Corporation (GERN)
  • Journey Medical Corp. (DERM)
  • Kymera Therapeutics, Inc. (KYMR)
  • Longboard Pharmaceuticals, Inc. (LBPH)
  • Mirati Therapeutics, Inc. (MRTX)
  • Rigel Pharmaceuticals, Inc. (RIGL)
  • Syndax Pharmaceuticals, Inc. (SNDX)
  • Verastem Oncology, Inc. (VSTM) 
  • Viridian Therapeutics, Inc. (VRDN)
  • X4 Pharmaceuticals, Inc. (XFOR)


Kalpit Patel is a Senior Biotech Analyst with B. Riley Securities responsible for covering emerging companies within the oncology and immunology sectors. He has 15 years of experience in the healthcare field.

Prior to joining B. Riley, he was a director at Oppenheimer covering early-stage biotech companies. He also spent several years as a pharmacist before embarking on a Wall Street career.

Mr. Patel is a registered pharmacist in Illinois. He received his MBA from The University of Chicago Booth School of Business and a Pharm.D. from the Massachusetts College of Pharmacy.

B. Riley Securities is a leading middle market investment bank that provides a full suite of corporate finance, advisory, sales and trading and equity research. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. B. Riley is nationally recognized and highly ranked for its proprietary equity research.